Arcutis Biotherapeutics, Inc. ARQT Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s software and technology licenses, net?
- Arcutis Biotherapeutics, Inc. (ARQT) reported software and technology licenses, net of $2.3M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s software and technology licenses, net increased by 285.2% year-over-year, from $596K to $2.3M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s software and technology licenses, net has grown at a 78.6% compound annual growth rate (CAGR), from $78K to $1.42M.